Laborie Medical Technologies, Inc., headquartered in California, is a leading innovator in the medical technology industry, specialising in urology and gastroenterology solutions. Founded in 1967, the company has established a strong presence in North America, Europe, and Asia, providing advanced diagnostic and therapeutic products that enhance patient care. With a diverse portfolio that includes urodynamics, pelvic floor therapy, and gastrointestinal diagnostics, Laborie is recognised for its commitment to quality and innovation. Their unique offerings, such as the advanced bladder scanner and comprehensive urodynamic systems, set them apart in a competitive market. Laborie's dedication to research and development has earned it a prominent position within the industry, making significant strides in improving clinical outcomes and patient experiences. As a trusted partner for healthcare professionals, Laborie continues to shape the future of medical technology.
How does Laborie Medical Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Laborie Medical Technologies, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Laborie Medical Technologies, Inc., headquartered in California, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Laborie has not inherited any emissions data from a parent or related organization, nor does it participate in any recognised climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the medical technology industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific commitments or data, Laborie's current climate impact and future goals remain unclear.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laborie Medical Technologies, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.